Parkinson’s Disease

« Previous Entries

Existing Tapeworm Infection Drug Might Help Treat Parkinson In Future

Thursday, December 14th, 2017

In a new research, experts have found that a drug that’s currently used for treating tapeworm infection might be able to offer protection against neuronal damage linked with Parkinson’s disease. These findings might help successfully treat—or even stop—neurodegeneration caused by Parkinson’s. Parkinson’s disease affects millions of people worldwide. In the U.S. alone, about 500,000 people […]

Regular Intense Workouts Might Delay Parkinsons Progression

Tuesday, December 12th, 2017

According to new research, high-intensity exercise might help delay the progression of Parkinson’s disease. A neurodegenerative disorder, Parkinson’s disease affects movement and is marked by uncontrolled tremors in the legs, arms, and other body parts. At present, it is estimated that nearly 1 million individuals in the U.S. have Parkinson’s. Every year, about 60,000 people […]

A Diabetes Drug Might Prove Beneficial Against Parkinson Disease

Friday, August 25th, 2017

Is exenatide a potential treatment for Parkinson’s disease? It might well be, according to a new study. Exenatide is used for treating diabetes. In a new study, the researchers found that it might be able to modify Parkinson’s, a progressive neurological disorder marked by muscular rigidity, tremor, and slow movements and which usually affects middle-aged […]

Low-fat dairy Linked to Increased Risk of Parkinson Disease

Tuesday, June 6th, 2017

Instead of full-fat dairy, many people consume low-fat kind because it is seen as more healthy. However, a recently-concluded study suggests that people who consume high amounts of low-fat dairy might carry an increased risk to Parkinson’s disease. In this study, the researchers noticed that the risk of developing Parkinson’s disease was higher for adults […]

A New Diabetes Drug Might Be Helpful Against Parkinson

Thursday, December 22nd, 2016

A drug originally designed for treating diabetes might be effective against Parkinson’s disease, according to new research. The name of the drug is MSDC-0160. It is an insulin sensitizer for tackling diabetes type 2. Parkinson’s disease is a progressive neurological condition in which certain nerve cells in the brain gradually die. Some of the dying […]

A New Drug Shows Promise to Treat Parkinson Disease

Friday, December 16th, 2016

A new drug has shown potential to treat Parkinson’s disease in mice induced to develop motor symptoms associated with this disease. The drug worked by clearing the clumps of a specific protein in the brain. A neurodegenerative brain disorder, Parkinson’s disease occurs due to lack of dopamine in the brain. Lack of dopamine causes four […]

Caffeine-Based Compounds Slow Parkinson Disease Progression, Study Finds

Monday, October 3rd, 2016

More than one study has hinted at caffeine’s ability to reduce the progression rate of Parkinson’s disease. Building on this suggestion, researchers created caffeine-based compounds which prevent formation of protein clumps in the brain, the chief characteristic of Parkinson’s. A neurological disorder which worsens with time and at present is incurable, Parkinson’s disease is estimated […]

Leukemia Medication Might Help Improve Symptoms of Parkinson and Dementia

Saturday, July 16th, 2016

A neurodegenerative brain disorder, Parkinson’s disease affects millions of people worldwide. The disease causes many motor as well as non-motor symptoms, most of which develop gradually over the years. The condition is incurable, but patients generally are able to live with it for many years. The condition itself is not fatal. However, complications arising from […]

FDA Gives Approval to Nuplazid for Treating Hallucinations & Delusions Linked to Parkinson Disease

Friday, May 6th, 2016

The FDA has given approval to Nuplazid for treating hallucinations and delusions experienced by Parkinson’s disease patients because of their underlying psychotic condition. Nuplazid is the first drug that has received approval from the FDA for treating hallucinations and delusions linked with psychosis. It is estimated that half of Parkinson’s patients experience hallucinations (defined as […]

Group Singing Improves Voice Defects and Quality of Life in Parkinson Patients

Friday, April 15th, 2016

According to a recent study, group singing can help alleviate some of those symptoms of Parkinson’s disease which current treatments do not target. Existing treatments focuses on controlling the motor symptoms, like tremors, balance problems, slowness in movement, etc. In addition to motor symptoms, Parkinson’s patients suffer breathing and voice impairments. It is estimated that […]

« Previous Entries